Pharmesis International Ltd. (SGX: BFK)
Singapore
· Delayed Price · Currency is SGD
0.465
+0.035 (8.14%)
Oct 14, 2024, 10:17 AM SGT
Pharmesis International Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Oct '24 Oct 11, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 15 | 3 | 3 | 3 | 7 | 5 | |
Market Cap Growth | -35.84% | 7.89% | -27.33% | -47.37% | 32.56% | -14.00% | |
Enterprise Value | 18 | 5 | 4 | 4 | 7 | 6 | |
Last Close Price | 0.47 | 0.10 | 0.11 | 0.15 | 0.28 | 0.21 | |
PE Ratio | - | -2.80 | -3.62 | 13.89 | -5.56 | -1.45 | |
PS Ratio | 1.66 | 0.32 | 0.26 | 0.31 | 0.69 | 0.69 | |
PB Ratio | 1.57 | 0.27 | 0.23 | 0.27 | 0.56 | 0.40 | |
P/FCF Ratio | -1.85 | -1.19 | 2.04 | -17.50 | 41.88 | -6.30 | |
P/OCF Ratio | -1.89 | -1.25 | 1.96 | 24.89 | 19.15 | 10.89 | |
EV/Sales Ratio | 2.26 | 0.57 | 0.42 | 0.39 | 0.78 | 0.77 | |
EV/EBITDA Ratio | -2.74 | -4.02 | -17.76 | 8.93 | -12.20 | -3.17 | |
EV/EBIT Ratio | -2.41 | -3.40 | -8.36 | 19.59 | -8.46 | -2.75 | |
EV/FCF Ratio | -12.70 | -2.12 | 3.34 | -22.41 | 47.32 | -7.08 | |
Debt / Equity Ratio | 0.31 | 0.30 | 0.29 | 0.28 | 0.27 | 0.25 | |
Debt / EBITDA Ratio | - | - | - | 5.89 | - | - | |
Debt / FCF Ratio | -2.19 | -1.36 | 2.61 | -18.45 | 20.53 | -3.93 | |
Asset Turnover | 0.51 | 0.50 | 0.53 | 0.57 | 0.51 | 0.33 | |
Inventory Turnover | 1.98 | 2.24 | 2.65 | 3.20 | 3.02 | 2.19 | |
Quick Ratio | 0.47 | 0.58 | 0.82 | 0.92 | 0.86 | 1.09 | |
Current Ratio | 1.08 | 1.09 | 1.12 | 1.21 | 1.14 | 1.33 | |
Return on Equity (ROE) | -14.74% | -8.82% | -5.42% | 3.32% | -9.57% | -23.63% | |
Return on Assets (ROA) | -7.58% | -5.17% | -1.66% | 0.72% | -2.92% | -5.89% | |
Return on Capital (ROIC) | -8.61% | -6.58% | -2.10% | 0.88% | -3.51% | -6.75% | |
Earnings Yield | -53.75% | -34.12% | -27.61% | 7.20% | -18.00% | -69.03% | |
FCF Yield | -54.06% | -83.72% | 49.06% | -5.71% | 2.39% | -15.87% | |
Buyback Yield / Dilution | -15.38% | -14.85% | - | - | - | - | |
Total Shareholder Return | -15.38% | -14.85% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.